Jane Street
CLVS

Jane Street’s Clovis Oncology, Inc. CLVS Stock Holding History

Jane Street’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,800
Closed -$39K – 10647
2022
Q3 		$39K Sell
32,800
-258,600
-89% -$403K ﹤0.01% 9021
2022
Q2 		$525K Buy
291,400
+59,400
+26% +$87.6K ﹤0.01% 6648
2022
Q1 		$469K Buy
232,000
+104,900
+83% +$206K ﹤0.01% 7615
2021
Q4 		$344K Sell
127,100
-16,500
-11% -$61K ﹤0.01% 7926
2021
Q3 		$640K Sell
143,600
-48,300
-25% -$233K ﹤0.01% 6811
2021
Q2 		$1.11M Buy
191,900
+700
+0.4% +$4.1K ﹤0.01% 5603
2021
Q1 		$1.34M Buy
191,200
+72,800
+61% +$488K ﹤0.01% 4850
2020
Q4 		$568K Sell
118,400
-21,700
-15% -$110K ﹤0.01% 5541
2020
Q3 		$817K Sell
140,100
-18,100
-11% -$108K ﹤0.01% 4422
2020
Q2 		$1.07M Buy
158,200
+114,300
+260% +$865K ﹤0.01% 3969
2020
Q1 		$279K Sell
43,900
-2,300
-5% -$18.4K ﹤0.01% 4294
2019
Q4 		$482K Buy
+46,200
New +$336K ﹤0.01% 3727
2019
Q2 		– Sell
-26,500
Closed -$658K – 5959
2019
Q1 		$658K Buy
+26,500
New +$664K ﹤0.01% 3339
2018
Q3 		– Sell
-18,900
Closed -$859K – 5893
2018
Q2 		$859K Buy
18,900
+7,700
+69% +$374K ﹤0.01% 2943
2018
Q1 		$591K Hold
11,200
– – ﹤0.01% 3292
2017
Q4 		$762K Sell
11,200
-1,100
-9% -$76.9K ﹤0.01% 2676
2017
Q3 		$1.01M Sell
12,300
-51,000
-81% -$4.04M ﹤0.01% 2292
2017
Q2 		$5.93M Buy
63,300
+30,300
+92% +$1.85M 0.02% 678
2017
Q1 		$2.1M Buy
33,000
+23,400
+244% +$1.42M 0.01% 1335
2016
Q4 		$426K Buy
9,600
+2,200
+30% +$77.4K ﹤0.01% 3012
2016
Q3 		$267K Buy
+7,400
New +$159K ﹤0.01% 3417
2015
Q3 		– Sell
-12,700
Closed -$1.12M – 4312
2015
Q2 		$1.12M Sell
12,700
-84,500
-87% -$7.23M 0.01% 1453
2015
Q1 		$7.21M Buy
+97,200
New +$6.86M 0.06% 285

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jane Street's CLVS Position: Q4 2022 in Review

Jane Street sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 52,609 shares — an estimated $63K sold.

Jane Street first reported a position in CLVS in Q2 2013 and held it in 29 quarters. The position peaked at $6.01M in Q3 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Jane Street reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 52,609 Clovis Oncology, Inc. shares in Q4 2022, an estimated $63K.
  • Jane Street first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 29 quarters.
  • Jane Street's Clovis Oncology, Inc. position peaked at $6.01M in Q3 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.